Provided by Tiger Fintech (Singapore) Pte. Ltd.

SINOPHARM

20.000
+0.3201.63%
Volume:3.96M
Turnover:79.01M
Market Cap:62.41B
PE:6.42
High:20.100
Open:19.920
Low:19.820
Close:19.680
Loading ...

Nomura Adjusts Sinopharm Group's Price Target to HK$25.09 From HK$28.46, Keeps at Buy

MT Newswires Live
·
27 Feb

Sinopharm Group Co. Ltd.'s (HKG:1099) Share Price Is Matching Sentiment Around Its Earnings

Simply Wall St.
·
26 Feb

Greater China Stocks Rise; Hong Kong Sees Largest Increase

Dow Jones
·
07 Feb

Sinopharm Group's Subsidiary Expects Up to 65% Lower Attributable Profit for 2024

MT Newswires Live
·
20 Jan

Sinopharm Group (HKG:1099) investors are sitting on a loss of 11% if they invested five years ago

Simply Wall St.
·
20 Jan

BRIEF-Sinopharm Group To Appoint Sun Jinglin As An Executive Director

Reuters
·
09 Jan

Sinopharm Group - to Appoint Sun Jinglin as an Executive Director

THOMSON REUTERS
·
08 Jan

China Healthcare Sector to Get Policy Boost in 1Q -- Market Talk

Dow Jones
·
07 Jan

Jinhai Medical Technology's Unit Authorizes Sinopharm to Solely Distribute Medical Devices in China

MT Newswires Live
·
03 Jan

Sinopharm Group (HKG:1099) Has A Pretty Healthy Balance Sheet

Simply Wall St.
·
30 Dec 2024

BRIEF-Citigroup's Long Position In H-Shares Of Sinopharm Group Decreases To 4.86% - HKEX

Reuters
·
24 Dec 2024

Citigroup's Long Position in H-Shares of Sinopharm Group Decreases to 4.86% on Dec 18 From 5.38% - HKEX

THOMSON REUTERS
·
24 Dec 2024

Greater China Stocks Close Mixed; Taiwan Leads Gainers

Dow Jones
·
25 Nov 2024

Sinopharm Group's (HKG:1099) Returns On Capital Not Reflecting Well On The Business

Simply Wall St.
·
07 Nov 2024

Sinopharm Group Records Lower Attributable Profit for Nine Months to September

MT Newswires Live
·
28 Oct 2024

BRIEF-Sinopharm Group Posts 9-Mths Total Operating Revenue Of RMB442.42 Bln

Reuters
·
28 Oct 2024